Jerrold Rosenbaum, MD
Dr. Rosenbaum, Stanley Cobb Professor of Psychiatry at Harvard Medical School, chaired the Massachusetts General Hospital Psychiatry Department for 20 years, leading 600 clinicians and researchers, and 150 trainees. The Psychiatry Department was ranked by U.S. News and World Report as #1 in the United States in 2019 and for 20 of the prior 24 years, with 60 specialty clinical and research programs and over 70 million dollars in annual research spending.
At Mass General, he served as Chair of the Executive Committee on Research. He was the 2007 recipient of the C. Charles Burlingame Award for lifetime achievement in psychiatric research and education and the 2016 recipient of the Joseph B. Martin Dean’s Leadership Award for the Advancement of Women Faculty for Harvard Medical School. He is Emeritus Fellow of the American College of Neuropsychopharmacology (ACNP). In 2018, he was an Ellis Island Medal of Honor awardee. He was President/Board Chair of the Anxiety and Depression Association of America (ADAA) and served as President and is a Board member of the American Foundation for Suicide Prevention.
He served a six-year term as Trustee of the Massachusetts General Hospital and was Trustee of the Partners Healthcare System. He is co-Chair of Development at Mass General. He’s co-authored more than 400 original articles and reviews and edited 20 books. He led longitudinal studies of children at risk for anxiety disorders and depression, which examined behavioral differences, risk factors, longitudinal outcomes, treatment, genetics and brain structure and function of children of parents with mood and anxiety disorders. He is currently directing The Center for Neuroscience of Psychedelics to understand how psychedelics change the brain and to explore novel mechanisms for treatment of psychiatric disorders. He co-founded Psy Therapeutics to advance the discovery of novel drugs for psychiatric and neurologic disorders and is co-founder of Sensorium Therapeutics, Inc. to explore plant derived molecules as leads for novel psychiatric therapeutics.
Dr. Rosenbaum received his undergraduate degree from Yale College in 1969 and his medical degree from Yale School of Medicine in 1973. He completed his residency and fellowship in Psychiatry at Massachusetts General Hospital, Harvard Medical School.